[A fundamental study on a bioassay for the antiphlogistic effect of topically applied antiinflammatory agents (author's transl)]. 1979

K Yamada, and S Hattori, and T Hakoda, and M Miyazaki, and T Tho, and T Furukawa

To establish a reliable laboratory assay for quantitating topical anti-inflammatory efficacy, the method of Tonelli et al was modified by employing felt fixed forceps, felt and sharp punch in Wistar rats. Croton oil, applied topically to the rat ear, elicited an acute phlogistic response which was maximal 6 hr after the application. The phlogistic response elicited by a single topical application of croton oil (1, 2, 5 and 10%) was increased in a dose-dependent manner, and croton oil, 5%, induced 63.2% increase of ear weight and was the optimal concentration for the experiment. Using this procedure, the antiphlogistic potencies of two corticoids were assayed under conditions of a blind test. ED50 of betamethasone valerate and diflucortolone valerate was 0.26 mg/ml and 0.0097 mg/ml, respectively, in Wistar rats, and 0.86 mg/ml and 0.016 mg/ml in Sprague Dawley rats, suggesting that diflucortolone valerate has an antiphlogistic potency of 27-56 relative to that seen with betamethasone valerate with minor differences in the strain of the rat. Our method should prove to be a useful assay for rapidly quantitating antiphlogistic activities of topically applied corticoids.

UI MeSH Term Description Entries
D008297 Male Males
D003436 Croton Oil Viscous, nauseating oil obtained from the shrub Croton tiglium (Euphorbaceae). It is a vesicant and skin irritant used as pharmacologic standard for skin inflammation and allergy and causes skin cancer. It was formerly used as an emetic and cathartic with frequent mortality. Oil, Croton
D004060 Diflucortolone A topical glucocorticoid used in various DERMATOSES. It is absorbed through the skin, bound to plasma albumin, and may cause adrenal suppression. It is also administered as the valerate. Ro 10-7614,Ro 10 7614,Ro 107614
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004423 Ear The hearing and equilibrium system of the body. It consists of three parts: the EXTERNAL EAR, the MIDDLE EAR, and the INNER EAR. Sound waves are transmitted through this organ where vibration is transduced to nerve signals that pass through the ACOUSTIC NERVE to the CENTRAL NERVOUS SYSTEM. The inner ear also contains the vestibular organ that maintains equilibrium by transducing signals to the VESTIBULAR NERVE. Vestibulocochlear System,Vestibulocochlear Apparatus,Apparatus, Vestibulocochlear,Ears,System, Vestibulocochlear
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents

Related Publications

K Yamada, and S Hattori, and T Hakoda, and M Miyazaki, and T Tho, and T Furukawa
January 1977, Arzneimittel-Forschung,
K Yamada, and S Hattori, and T Hakoda, and M Miyazaki, and T Tho, and T Furukawa
June 1981, Die Pharmazie,
K Yamada, and S Hattori, and T Hakoda, and M Miyazaki, and T Tho, and T Furukawa
January 1975, Experimentelle Pathologie,
K Yamada, and S Hattori, and T Hakoda, and M Miyazaki, and T Tho, and T Furukawa
January 1984, Clinics in dermatology,
K Yamada, and S Hattori, and T Hakoda, and M Miyazaki, and T Tho, and T Furukawa
February 1973, Nihon Shishubyo Gakkai kaishi,
K Yamada, and S Hattori, and T Hakoda, and M Miyazaki, and T Tho, and T Furukawa
December 1972, Archives of dermatology,
K Yamada, and S Hattori, and T Hakoda, and M Miyazaki, and T Tho, and T Furukawa
December 1955, Journal of the American Medical Association,
K Yamada, and S Hattori, and T Hakoda, and M Miyazaki, and T Tho, and T Furukawa
February 1974, Nihon Shishubyo Gakkai kaishi,
K Yamada, and S Hattori, and T Hakoda, and M Miyazaki, and T Tho, and T Furukawa
May 1996, Methods and findings in experimental and clinical pharmacology,
K Yamada, and S Hattori, and T Hakoda, and M Miyazaki, and T Tho, and T Furukawa
June 1980, Klinische Monatsblatter fur Augenheilkunde,
Copied contents to your clipboard!